avanafil
Ligand Summary
a selective inhibitor of cGMP-specific PDE5 has no direct relaxant effect on isolated human corpus cavernosum, but enhances the effect of NO by inhibiting PDE5, which is responsible for degradation of cGMP in the corpus cavernosum
UNII: DR5S136IVO
PubChem: 9869929
ChEMBL: CHEMBL1963681
DrugCentral: 4305
LyCHI: KXZCSCHT87M3
Target Activities
26 Activities
Items per page:
10
1 – 10 of 26
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||